A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP

Biological Psychiatry

Volumn 33, Issue 1, 1993, Pages 3-14

  Pigott, Teresa A ^a   Hill, James L ^a   Grady, Tana A ^c   L'Heureux, Francine ^a   Bernstein, Suzanne ^b   Rubenstein, Cheryl S ^a   Murphy, Dennis L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; METERGOLINE; PLACEBO; SEROTONIN RECEPTOR;

ADULT; ANXIETY; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OBSESSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; COMPULSIVE PERSONALITY DISORDER; FEMALE; HUMAN; INJECTIONS, INTRAVENOUS; MALE; METERGOLINE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN AGONISTS;

EID: 0027458735     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(93)90272-F     Document Type: Article

References (41)

1. Clomipramine in obsessive-compulsive disorder: further evidence for a serotonergic mechanism of action
2. 1-Methyl-8beta-carbobenzyloxy-aminomethyl-10-alpha-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist
3. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam
4. Serotonin function in obsessive-compulsive disorder: A comparison of the effects of tryptophan and m-CPP in patients and healthy subjects
5. m-CPP: a tool for studying behavioral responses associated with 5-HT1c receptors
6. Effects of metergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors
7. 1-m-CPP interactions with neurotransmitter receptors in the human brain
8. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to m-CPP in obsessive-compulsive disorder
9. Serotonergic function in obsessive-compulsive disorder
10. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings
11. 1 recognition sites
12. 3H]ICS
13. OCD: a double-blind trial of clomipramine and clorgyline
14. Serotonin Dysfunction in Schizophrenia
15. Subjective and physiological responses of patients with seasonal affective disorder and controls to intravenous m-CPP
16. Effects of serotonin antagonists on m-CPP-mediated responses in normal subjects
17. Serotonin receptor sensitivity in schizophrenia
18. Behavioral hypersensitivity to m-CPP in a subject with subclinical panic attacks
19. Anxiolytic-like actions of BRL 46470-a novel 5-HT3 antagonist
20. Evidence that m-CPP may have behavioral effects mediated by central 5-HT1c receptors
21. Anxiogenic-like effects of m-CPP and TFMPP in animal models are opposed by 5-HT1c receptor antagonists
22. Identification and distribution of 5-ht3 receptors in rat brain using radioligand binding
23. On the mode of prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine
24. Hyperresponsitivity to the serotonin agonist m-CPP in Alzheimer's disease: a controlled study
25. Further studies of the putative serotonin agonist m-CPP Evidence for a serotonin receptor mediated mechanism of action in humans
26. Neuropsychiatric disorders and the multiple human brain serotonin receptors subtypes and subsystems
27. Pharmacological Treatment of Obsessive-Compulsive Disorder
28. Methods for the quantitative assessment of depressive and manic behavior
29. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-CPP given intravenously or orally to normal volunteers
30. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans
31. Serotonergic Responsivity in Schizophrenia
32. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder
33. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-CPP in patients with OCD
34. Metergoline as a selective 5-HT antagonists in the cerebral cortex
35. Interaction of metergoline with striatal dopamine system
36. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to m-CPP in healthy human subjects
37. 5-HT function in the biochemical and behavioral responses to m-CPP in healthy subjects and schizophrenics
38. Clomipramine treatment of obsessive-compulsive disorder: I. A controlled clinical trial
39. Serotonergic responsitivity in obsessive-compulsive disorder: comparison of patients and healthy controls
40. Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment